We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Pays $34.7M To Settle Genotropin Charges

Law360 (April 2, 2007, 12:00 AM EDT) -- Pfizer Inc. has agreed to pay fines of $34.7 million to settle allegations two subsidiaries engaged in illegal off-label marketing and paid kickbacks to a vendor to boost sales of human growth hormone Genotropin, the drug maker said Monday.

Two subsidiaries of Pfizer unit Pharmacia reached separate settlements with the U.S. Department of Justice for activities that occurred at Pharmacia before it was acquired by Pfizer in 2003, Pfizer said.

One subsidiary—Pharmacia & Upjohn Company Inc.—will plead guilty to a single count of offering to an...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.